Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
Clinical trial NCT01447225 · COMPLETED
Trial details
- NCT number
- NCT01447225
- Sponsor
- Merrimack Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-11-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.